MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Perceptions of Fluctuation Treatment in Parkinson’s Disease Impact Suicidality

    J. Hinkle, K. Perepezko, Z. Mari, L. Marsh, G. Pontone (Baltimore, MD, USA)

    Objective: Our goal was to examine the relationship between suicidality and motor fluctuations in Parkinson’s disease (PD) patients. Background: On/off motor fluctuations in PD are…
  • 2017 International Congress

    Domain-Specific Cognitive Impairment in Non-Demented Parkinson’s Disease Psychosis

    J. Hinkle, K. Perepezko, C. Bakker, T. Dawson, V. Johnson, Z. Mari, C. Marvel, K. Mills, A. Pantelyat, O. Pletnikova, L. Rosenthal, M. Shepard, D. Stevens, J. Troncoso, J. Wang, G. Pontone (Baltimore, MD, USA)

    Objective: Our objective was to determine whether psychosis in non-demented Parkinson’s disease (PD) patients is associated with domain-specific cognitive impairment on the Mini-Mental State Exam…
  • 2017 International Congress

    Othello syndrome amongst patients with Parkinson’s disease in a rural movement disorders clinic in western India

    S. Desai, D. Desai (Anand, India)

    Objective: To assess the prevalence of Othello syndrome amongst patients with Parkinson’s disease in a rural based movement disorders clinic.  Background:  Othello syndrome (OS) is…
  • 2017 International Congress

    Suicidality in Parkinson’s Disease: A Case Control Study

    M. Akbostanci, E. Bayram, D. Sayar, T. Ayidaga (Ankara, Turkey)

    Objective: To investigate suicidality in Parkinson's disease (PD) by a case control study Background: Depression, a risk factor for suicidality, is rather common in PD patients. Nevertheless,…
  • 2017 International Congress

    Short term effects of bilateral STN DBS on psychiatric profile in Parkinson’s disease

    R. Alugolu, M.B. Kesani, B. Ganji, V. Mudumba, R. Mrudula, R. Borgohain, P. Gaddamanugu (Hyderabad, India)

    Objective: We intend to look into the effects of bilateral STN DBS on Psychiatric profile of Parkinson’s patients. Background: Parkinson’s disease is a well-known degenerative…
  • 2017 International Congress

    Absence of depression in de novo Parkinson’s disease: a benign motor phenotype?

    H.S. YOO, Y. Lee, J.J. Lee, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Republic of Korea)

    Objective: This study aimed to assess the impact of early depression on motor deficits relative to the level of striatal dopaminergic depletion in patients with…
  • 2017 International Congress

    Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD Study

    N. Dissanayaka, N. Pachana, J. O'Sullivan, R. Marsh, P. Silburn, E. White, E. Torbey, D. Pye, L. Mitchell, J.H. Yang, T. Au, G. Mellick, D. Copland, A. Toft, G. Byrne (Brisbane, Australia)

    Objective: We investigated PD-specific features of anxiety for clear conceptualisation, and assessed targeted psychotherapy for anxiety in Parkinson’s disease (PD). Background: Anxiety is poorly diagnosed in PD…
  • 2017 International Congress

    Treatment of Psychosis in Parkinson’s Disease: Evidence-Based Recommendations Versus Actual Clinical Practice

    L.G. Chan, A. Kong, L. Tan (Singapore, Singapore)

    Objective: To examine if actual clinical practice of antipsychotic use in Parkinson's Disease patients are consistent with published evidence-based reviews of treatment recommendations and discuss…
  • 2017 International Congress

    Electrophysiological markers for emotional and cognitive impairment in Parkinson’s disease

    N. Dissanayaka, T. Au, A. Angwin, J. O'Sullivan, G. Byrne, P. Silburn, R. Marsh, G. Mellick, D. Copland (Brisbane, Australia)

    Objective: This study aims to identify markers for emotional and cognitive dysfunctions in Parkinson’s disease (PD) using non-invasive electroencephalography (EEG). This study investigates event related…
  • 2017 International Congress

    The role of habenula and amygdala dysfunction in Parkinson’s disease patients with punding

    V. Markovic, F. Agosta, E. Canu, A. Inuggi, I. Petrovic, I. Stankovic, F. Imperiale, T. Stojkovic, V. Kostic, M. Filippi (Belgrade, Serbia)

    Objective: To assess whether a functional dysregulation of the habenula and amygdala, as modulators of the reward brain circuit, contributes to Parkinson’s disease (PD)-punding. Background:…
  • « Previous Page
  • 1
  • …
  • 1478
  • 1479
  • 1480
  • 1481
  • 1482
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley